๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity

โœ Scribed by Suzanne L Topalian; Charles G Drake; Drew M Pardoll

Book ID
116373485
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
383 KB
Volume
24
Category
Article
ISSN
0952-7915

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The STATus of PD-L1 (B7-H1) on tolerogen
The STATus of PD-L1 (B7-H1) on tolerogenic APCs
โœ Tina L. Sumpter; Angus W. Thomson ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 174 KB

## Abstract Expression by DCs of coโ€inhibitory molecules such as programmed death ligandโ€1 (PDโ€L1/B7โ€H1/CD274), a member of the B7 superfamily, is crucial for the downregulation of Tโ€cell responses and the maintenance of immune homeostasis. Exposure of immature DCs to dangerโ€associated molecular pa

Blockade of PD-L1 (B7-H1) augments human
Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro
โœ Christian Blank; Juergen Kuball; Simon Voelkl; Heinz Wiendl; Bernd Becker; Bernh ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 559 KB

## Abstract Human tumors frequently escape immune destruction, despite the presence of cyototoxic T cells (CTL) recognizing tumorโ€associated antigens (TAA). We have previously shown that programmed death ligandโ€1 (PDโ€L1), a recently identified ligand of the B7 superfamily, is expressed on murine tu